| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $22.2M | -3.1% | +30.2% |
| SG&A Expense | $5.7M | -0.1% | -7.6% |
| Operating Income | -$27.9M | +2.5% | -20.1% |
| Pre-tax Income | -$26.1M | +3.2% | -24.3% |
| Income Tax | $26K | -45.8% | -39.5% |
| Net Income | -$26.1M | +3.3% | -24.2% |
| EPS (Basic) | -$0.40 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.6M | -55.7% | +87.2% |
| Current Assets | $170.1M | -7.5% | -7.3% |
| Total Assets | $190.0M | -7.0% | -7.5% |
| Current Liabilities | $18.8M | +26.7% | +27.9% |
| Total Liabilities | $33.4M | +12.1% | +8.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$64.3M | — | — |
| Capital Expenditures | $271K | — | — |
| Investing Cash Flow | $5.8M | — | — |
| Financing Cash Flow | $74.4M | — | — |
| Free Cash Flow | -$64.5M | — | — |
| +14.9% |
| +4.8% |
| EPS (Diluted) | -$0.40 | +14.9% | +4.8% |
| $156.7M |
| -10.3% |
| -10.3% |